CORV. stock pitch - 2019-12-02

Added to YB: 2019-12-02

Pitch date: 2019-12-02

Correvio Pharma Corp.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Correvio Pharma Corp., a specialty pharmaceutical company, engages in developing therapeutics worldwide.

Market Cap

CAD 26.8M

Pitch Price

CAD 2.77

Price Target

N/A

Dividend

N/A

EV/EBITDA

N/A

P/E

-0.51

EV/Sales

N/A

Sector

Pharmaceuticals

A summary for this pitch has not been created yet.